Stereotactic Body Radiotherapy for Localized Kidney Cancer
Authors:
- 16 November 2022
- journal article
- research article
- Published by Springer Nature in Current Urology Reports
- Vol. 23 (12) , 371-381
Abstract
Purpose of Review Stereotactic body radiation therapy (SBRT) is increasingly utilized in the management of localized kidney cancers, particularly for patients who are not surgical candidates. Herein, we provide a narrative review of SBRT in the management of localized kidney cancers. Recent Findings Recent prospective studies and multi-institutional retrospective studies highlight the safety and efficacy of SBRT in the management of renal tumors, a disease previously thought to be radioresistant. Studies have shown that local control is greater than 90% with rare grade 3 or 4 toxicity and no grade 5 toxicity. SBRT can be utilized successfully in the treatment of large kidney tumors (> 5 cm). New techniques such as MRI-guided radiation therapy may further improve the therapeutic ratio. However, randomized clinical trials are necessary to confirm the optimal dosing schedule and compare outcomes with nephrectomy, which remains the standard of care in suitable patients. Summary Advances in SBRT have made this modality a safe and effective treatment option in the management of localized kidney cancers.Keywords
This publication has 75 references indexed in Scilit:
- An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapyRadiation Oncology, 2013
- Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombusUrologic Oncology: Seminars and Original Investigations, 2013
- Tumor Control Outcomes After Hypofractionated and Single-Dose Stereotactic Image-Guided Intensity-Modulated Radiotherapy for Extracranial Metastases From Renal Cell CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local controlRadiation Oncology, 2011
- Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend AnalysisEuropean Urology, 2011
- Complexity of tumor vasculature in clear cell renal cell carcinomaCancer, 2009
- Endothelial Function of von Hippel-Lindau Tumor Suppressor Gene: Control of Fibroblast Growth Factor Receptor SignalingCancer Research, 2008
- Tumor Response to Radiotherapy Regulated by Endothelial Cell ApoptosisScience, 2003
- Palliative Irradiation for Focally Symptomatic Metastatic Renal Cell CarcinomaJournal of Urology, 1997
- INCREASED INCIDENTAL DETECTION AND REDUCED MORTALITY IN RENAL CANCER—RECENT RETROSPECTIVE ANALYSIS AT EIGHT INSTITUTIONSInternational Journal of Urology, 1995